Market Reports Center

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016


Report Details

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

SKU GDSEP291653
Category Medical Devices
Publisher Globaldata
Pages 402
Published Sep-16
Request Discount Pay by Wire/Invoice

Description

Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016

Summary

GlobalData's Medical Devices sector report, “Injectable Drug Delivery - Medical Devices Pipeline Assessment, 2016" provides an overview of Injectable Drug Delivery currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Injectable Drug Delivery pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Injectable Drug Delivery under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Injectable Drug Delivery and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to -
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Injectable Drug Delivery under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date


News/Press Release

Table of Content

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 11
1.2 List of Figures 19
2 Introduction 20
2.1 Injectable Drug Delivery Overview 20
3 Products under Development 21
3.1 Injectable Drug Delivery - Pipeline Products by Stage of Development 21
3.2 Injectable Drug Delivery - Pipeline Products by Segment 22
3.3 Injectable Drug Delivery - Pipeline Products by Territory 23
3.4 Injectable Drug Delivery - Pipeline Products by Regulatory Path 24
3.5 Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 25
3.6 Injectable Drug Delivery - Ongoing Clinical Trials 26
4 Injectable Drug Delivery - Pipeline Products under Development by Companies 27
4.1 Injectable Drug Delivery Companies - Pipeline Products by Stage of Development 27
4.2 Injectable Drug Delivery - Pipeline Products by Stage of Development 31
5 Injectable Drug Delivery Companies and Product Overview 35
5.1 Aciont Inc. Company Overview 35
5.2 Actavis Inc. Company Overview 37
5.3 AdrenaCard, Inc. Company Overview 38
5.4 Allergan, Inc. Company Overview 39
5.5 Alsensa ApS Company Overview 40
5.6 AMAG Pharmaceuticals, Inc. Company Overview 41
5.7 Amgen Inc. Company Overview 43
5.8 Antares Pharma, Inc. Company Overview 45
5.9 Anterion Therapeutics, Inc. (Inactive) Company Overview 51
5.10 Arnali, LLC Company Overview 54
5.11 Artemes Technologies, Inc. Company Overview 55
5.12 AstraZeneca Plc Company Overview 56
5.13 Atanse, Inc. Company Overview 58
5.14 AzureBio, S.L. Company Overview 60
5.15 Becton, Dickinson and Company Company Overview 61
5.16 Bespak Europe Ltd. Company Overview 65
5.17 Biodel Inc. Company Overview 68
5.18 BioMarin Pharmaceutical Inc. Company Overview 70
5.19 BioRestorative Therapies, Inc. Company Overview 72
5.20 Boston University Company Overview 74
5.21 BTG Plc Company Overview 75
5.22 Burke Pharmaceuticals, LLC Company Overview 77
5.23 Callisyn Biomedical Inc Company Overview 78
5.24 Cambridge Consultants Limited Company Overview 81
5.25 Case Western Reserve University Company Overview 82
5.26 Cincinnati Children's Hospital Medical Center Company Overview 83
5.27 Clearside BioMedical, Inc. Company Overview 84
5.28 Consort Medical plc Company Overview 88
5.29 Credence MedSystems, Inc. Company Overview 89
5.30 CrossCoat Medical LLC Company Overview 90
5.31 Cytosial Biomedic, S.a.s. Company Overview 91
5.32 DALI Medical Devices Ltd. Company Overview 92
5.33 Delcath Systems, Inc. Company Overview 96
5.34 DelSite, Inc. (Inactive) Company Overview 101
5.35 Elcam Medical Company Overview 102
5.36 EmboMedics Company Overview 106
5.37 Emergent BioSolutions Inc. Company Overview 107
5.38 Eveon SAS Company Overview 109
5.39 Ghent University Company Overview 110
5.40 Hannover Medical School Company Overview 111
5.41 Indian Institute of Science Company Overview 112
5.42 Inovio Pharmaceuticals, Inc. Company Overview 113
5.43 LyoGo Company Overview 115
5.44 Medicom Innovation Partner a/s Company Overview 116
5.45 Meridian Medical Technologies, Inc. Company Overview 117
5.46 Mertiva AB Company Overview 118
5.47 Microchips Biotech, Inc. Company Overview 119
5.48 Midatech Pharma Plc Company Overview 121
5.49 Milestone Scientific Inc. Company Overview 123
5.50 North Carolina State University Company Overview 126
5.51 Ocelus Company Overview 128
5.52 Oval Medical Technologies Limited Company Overview 129
5.53 Particle Therapeutics Ltd Company Overview 130
5.54 Pfizer Inc. Company Overview 131
5.55 Portal Instruments, Inc. Company Overview 133
5.56 pSivida Corp. Company Overview 134
5.57 Ratio, Inc. Company Overview 139
5.58 Recon Therapeutics, LLC Company Overview 141
5.59 Replenish Inc Company Overview 142
5.60 RepliCel Life Sciences, Inc. Company Overview 144
5.61 RetinaPharma Technologies, Inc. Company Overview 145
5.62 Rx Safes, Inc. Company Overview 146
5.63 Scandinavian Health Ltd Company Overview 147
5.64 Shire Plc Company Overview 148
5.65 Spine Smith, LP Company Overview 150
5.66 Sun Pharmaceutical Industries Limited Company Overview 151
5.67 TCB medical devices Company Overview 153
5.68 Teva Pharmaceutical Industries Ltd. Company Overview 154
5.69 Texas Tech University Company Overview 156
5.70 TheraKine Ltd. (Inactive) Company Overview 157
5.71 Unilife Corporation Company Overview 159
5.72 United Therapeutics Corporation Company Overview 162
5.73 University College London Company Overview 164
5.74 University of Auckland Company Overview 165
5.75 University of Calgary Company Overview 166
5.76 University of California, Irvine Company Overview 167
5.77 University of California, San Diego Company Overview 168
5.78 University of California, San Francisco Company Overview 169
5.79 University of Delaware Company Overview 170
5.80 University of Dundee Company Overview 171
5.81 University of Florida Company Overview 172
5.82 University of Missouri Company Overview 175
5.83 University of Saskatchewan Company Overview 176
5.84 University of Texas at Austin Company Overview 177
5.85 Urodelia SA Company Overview 179
5.86 Vanderbilt University Company Overview 180
6 Injectable Drug Delivery- Recent Developments 181
6.1 Aug 29, 2016: Mylan to Launch First Generic to EpiPen Auto-Injector at a List Price of $300 per Two-Pack Carton, a More than 50% Discount to the Brand Product 181
6.2 Aug 29, 2016: pSivida Announces 13 New Patents Issued or Allowed 182
6.3 Aug 29, 2016: Catalent Reports Fourth Quarter and Fiscal Year 2016 Results 182
6.4 Aug 25, 2016: Mylan Taking Immediate Action To Further Enhance Access To EpiPen (Epinephrine Injection, USP) Auto-Injector 185
6.5 Aug 25, 2016: Medtronic Reports First Quarter Financial Results 186
6.6 Aug 24, 2016: Senators Ask FDA to Account for Any Alternatives to the EpiPen Amid Product Cost Increases 188
6.7 Aug 24, 2016: Hillary Clinton Statement on EpiPen Pricing 189
6.8 Aug 24, 2016: Milestone Scientific Begins Transition From a Product Development to a Business Development Company 189
6.9 Aug 22, 2016: Mylan's Commitment to EpiPen (epinephrine injection, USP) Auto-Injector Access 190
6.10 Aug 17, 2016: Consort Medical Announces Directorate Change 191
6.11 Aug 16, 2016: Delcath Announces Second Quarter Financial Results 192
6.12 Aug 15, 2016: MRI Interventions Announces 2016 Second Quarter and Six Month Results 193
6.13 Aug 12, 2016: Milestone Scientific Reports 34% Increase in Revenue for the Second Quarter of 2016 197
6.14 Aug 11, 2016: Biodel Reports Third Quarter Fiscal Year 2016 Financial Results 198
6.15 Aug 11, 2016: Clearside Biomedical Reports Second Quarter 2016 Financial Results 198
6.16 Aug 09, 2016: Primary Endpoint Met in pSivida's Utilization Study of New Medidur Inserter with Smaller Diameter Needle 199
6.17 Aug 09, 2016: BioMarin Pharma Prices Public Offering of Shares for USD720 Million 200
6.18 Aug 09, 2016: Mylan Reports Strong Second Quarter 2016 Results Including Total Revenues Up 8% 200
6.19 Aug 09, 2016: Antares Pharma Reports Second Quarter 2016 Operating and Financial Results 203
6.20 Aug 09, 2016: Halozyme Reports Second Quarter 2016 Financial Results 205
6.21 Aug 05, 2016: Caverion delivers a Large Project for Novo Nordisk’s new insulin production facility in Hillerod, Denmark 206
6.22 Aug 05, 2016: Novo Nordisk increased adjusted operating profit by 8% in local currencies in the first six months of 2016 207
6.23 Aug 04, 2016: Teva Reports Second Quarter 2016 Results 207
6.24 Aug 04, 2016: BD Announces Results For 2016 Third Fiscal Quarter 212
6.25 Aug 04, 2016: Merck Lifts Forecast Following Good Second Quarter 213
6.26 Aug 04, 2016: Emergent BioSolutions Reports Second Quarter and Six Months 2016 Financial Results 216
6.27 Aug 03, 2016: pSivida Names Dario Paggiarino, M.D. as Chief Medical Officer 219
6.28 Aug 02, 2016: Merck and Allergan May Acquire Biogen 219
6.29 Aug 02, 2016: Pfizer Reports Second-Quarter 2016 Results 219
6.30 Aug 02, 2016: Shire Delivers Strong Q2 2016 Revenue Growth; Upgrades Outlook 223
6.31 Aug 01, 2016: BCWorld Pharm Raises USD1.8 Million in Private Placement of Shares 228
6.32 Aug 01, 2016: Aptevo Therapeutics Completes Separation from Emergent BioSolutions 228
6.33 Aug 01, 2016: Clearside Biomedical Announces Promotion of Glenn Noronha, Ph.D. to Chief Scientific Officer and Jennifer M. Kissner, Ph.D. to Vice President, Clinical Development 228
6.34 Aug 01, 2016: Emergent BioSolutions Completes Spin-Off of Aptevo Therapeutics 229
7 Appendix 397
7.1 Methodology 397
7.2 About GlobalData 399
7.3 Contact Us 399
7.4 Disclaimer 400

List of Figures

1.1 List of Tables
Table 1: Injectable Drug Delivery - Pipeline Products by Stage of Development 23
Table 2: Injectable Drug Delivery - Pipeline Products by Segment 24
Table 3: Injectable Drug Delivery - Pipeline Products by Territory 25
Table 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path 26
Table 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 27
Table 6: Injectable Drug Delivery - Ongoing Clinical Trials 28
Table 7: Injectable Drug Delivery Companies - Pipeline Products by Stage of Development 29
Table 8: Injectable Drug Delivery - Pipeline Products by Stage of Development 33
Table 9: Aciont Inc. Pipeline Products & Ongoing Clinical Trials Overview 37
Table 10: DSP - Visulex - Product Status 37
Table 11: DSP - Visulex - Product Description 38
Table 12: Visulex-I - Product Status 38
Table 13: Visulex-I - Product Description 38
Table 14: Actavis Inc. Pipeline Products & Ongoing Clinical Trials Overview 39
Table 15: Epinephrine Pre-Filled Syringe - Product Status 39
Table 16: Epinephrine Pre-Filled Syringe - Product Description 39
Table 17: AdrenaCard, Inc. Pipeline Products & Ongoing Clinical Trials Overview 40
Table 18: Adrenacard Auto-Injector - Product Status 40
Table 19: Adrenacard Auto-Injector - Product Description 40
Table 20: Allergan, Inc. Pipeline Products & Ongoing Clinical Trials Overview 41
Table 21: NOVADUR Intravitreal Implant - Product Status 41
Table 22: NOVADUR Intravitreal Implant - Product Description 41
Table 23: Alsensa ApS Pipeline Products & Ongoing Clinical Trials Overview 42
Table 24: SQJCT - Product Status 42
Table 25: SQJCT - Product Description 42
Table 26: AMAG Pharmaceuticals, Inc. Pipeline Products & Ongoing Clinical Trials Overview 43
Table 27: Makena Auto-Injector - Product Status 43
Table 28: Makena Auto-Injector - Product Description 44
Table 29: Amgen Inc. Pipeline Products & Ongoing Clinical Trials Overview 45
Table 30: Repatha Pushtronex System - Product Status 45
Table 31: Repatha Pushtronex System - Product Description 46
Table 32: Antares Pharma, Inc. Pipeline Products & Ongoing Clinical Trials Overview 47
Table 33: Teva Pen 1 - Product Status 47
Table 34: Teva Pen 1 - Product Description 48
Table 35: Vibex EPI - Product Status 48
Table 36: Vibex EPI - Product Description 48
Table 37: Vibex Mini-Needle Injectors - Product Status 49
Table 38: Vibex Mini-Needle Injectors - Product Description 49
Table 39: Vibex Qs - Next Generation Makena - Product Status 49
Table 40: Vibex Qs - Next Generation Makena - Product Description 50
Table 41: Vibex QS M - Product Status 50
Table 42: Vibex QS M - Product Description 50
Table 43: Vibex QS T - Product Status 51
Table 44: Vibex QS T - Product Description 51
Table 45: VIBEX Sumatriptan - Product Status 51
Table 46: VIBEX Sumatriptan - Product Description 52
Table 47: Anterion Therapeutics, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 53
Table 48: Ambulin - Product Status 53
Table 49: Ambulin - Product Description 53
Table 50: Choless - Product Status 54
Table 51: Choless - Product Description 54
Table 52: Complimens - Product Status 54
Table 53: Complimens - Product Description 55
Table 54: Arnali, LLC Pipeline Products & Ongoing Clinical Trials Overview 56
Table 55: Arnali Drug Delivery Device - Product Status 56
Table 56: Arnali Drug Delivery Device - Product Description 56
Table 57: Artemes Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 57
Table 58: Artemes Magnetic Injection System - Product Status 57
Table 59: Artemes Magnetic Injection System - Product Description 57
Table 60: AstraZeneca Plc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 61: Second Generation Bydureon Pen - Product Status 58
Table 62: Second Generation Bydureon Pen - Product Description 59
Table 63: Atanse, Inc. Pipeline Products & Ongoing Clinical Trials Overview 60
Table 64: CEDSYS - Product Status 60
Table 65: CEDSYS - Product Description 60
Table 66: Intracerebral Microinjection Instrument - Product Status 61
Table 67: Intracerebral Microinjection Instrument - Product Description 61
Table 68: AzureBio, S.L. Pipeline Products & Ongoing Clinical Trials Overview 62
Table 69: Injectable Needle - Product Status 62
Table 70: Injectable Needle - Product Description 62
Table 71: Becton, Dickinson and Company Pipeline Products & Ongoing Clinical Trials Overview 63
Table 72: BD Libertas Patch Injector - Product Status 63
Table 73: BD Libertas Patch Injector - Product Description 64
Table 74: BD Physioject Disposable AutoInjector - Product Status 64
Table 75: BD Physioject Disposable AutoInjector - Product Description 64
Table 76: BD Simplist Prefilled Injectable - Heparin Sodium - Product Status 65
Table 77: BD Simplist Prefilled Injectable - Heparin Sodium - Product Description 65
Table 78: BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Status 65
Table 79: BD Simplist Prefilled Injectable - Hydromorphone Hydrochloride - Product Description 66
Table 80: Bespak Europe Ltd. Pipeline Products & Ongoing Clinical Trials Overview 67
Table 81: INJ570 Autoinjector - Product Status 67
Table 82: INJ570 Autoinjector - Product Description 67
Table 83: INJ650 ASI Auto-Injector - Product Status 68
Table 84: INJ650 ASI Auto-Injector - Product Description 68
Table 85: INJ700 Lila Mix Injector - Product Status 68
Table 86: INJ700 Lila Mix Injector - Product Description 69
Table 87: Biodel Inc. Pipeline Products & Ongoing Clinical Trials Overview 70
Table 88: EZMix Glucagon Rescue Device - Product Status 70
Table 89: EZMix Glucagon Rescue Device - Product Description 71
Table 90: BioMarin Pharmaceutical Inc. Pipeline Products & Ongoing Clinical Trials Overview 72
Table 91: PEG PAL Pre-filled Syringe - Product Status 72
Table 92: PEG PAL Pre-filled Syringe - Product Description 73
Table 93: BioRestorative Therapies, Inc. Pipeline Products & Ongoing Clinical Trials Overview 74
Table 94: brtxDISC Stem Cell Delivery Device - Product Status 74
Table 95: brtxDISC Stem Cell Delivery Device - Product Description 75
Table 96: Boston University Pipeline Products & Ongoing Clinical Trials Overview 76
Table 97: Polymeric Drug Delivery System - Product Status 76
Table 98: Polymeric Drug Delivery System - Product Description 76
Table 99: BTG Plc Pipeline Products & Ongoing Clinical Trials Overview 77
Table 100: Varithena - Product Status 77
Table 101: Varithena - Product Description 78
Table 102: Varithena - Aesthetic Leg Veins - Product Status 78
Table 103: Varithena - Aesthetic Leg Veins - Product Description 78
Table 104: Burke Pharmaceuticals, LLC Pipeline Products & Ongoing Clinical Trials Overview 79
Table 105: BURKE201 Needle Injection Pen - Product Status 79
Table 106: BURKE201 Needle Injection Pen - Product Description 79
Table 107: Callisyn Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview 80
Table 108: 8Spheres Embolic Microspheres - Product Status 80
Table 109: 8Spheres Embolic Microspheres - Product Description 81
Table 110: Callispheres PVA Embolic Microspheres - Product Status 81
Table 111: Callispheres PVA Embolic Microspheres - Product Description 81
Table 112: TACEspheres Drug Eluting Embolic Microspheres - Product Status 82
Table 113: TACEspheres Drug Eluting Embolic Microspheres - Product Description 82
Table 114: Cambridge Consultants Limited Pipeline Products & Ongoing Clinical Trials Overview 83
Table 115: Flexi-ject - Product Status 83
Table 116: Flexi-ject - Product Description 83
Table 117: Case Western Reserve University Pipeline Products & Ongoing Clinical Trials Overview 84
Table 118: Pressure Driven Local Drug Delivery System - Liver Cancer - Product Status 84
Table 119: Pressure Driven Local Drug Delivery System - Liver Cancer - Product Description 84
Table 120: Cincinnati Children's Hospital Medical Center Pipeline Products & Ongoing Clinical Trials Overview 85
Table 121: Pre-Filled Syringe With Flush - Product Status 85
Table 122: Pre-Filled Syringe With Flush - Product Description 85
Table 123: Clearside BioMedical, Inc. Pipeline Products & Ongoing Clinical Trials Overview 86
Table 124: SCS Microinjector - Product Status 86
Table 125: SCS Microinjector - Product De
1.2 List of Figures
Figure 1: Injectable Drug Delivery - Pipeline Products by Stage of Development 23
Figure 2: Injectable Drug Delivery - Pipeline Products by Segment 24
Figure 3: Injectable Drug Delivery - Pipeline Products by Territory 25
Figure 4: Injectable Drug Delivery - Pipeline Products by Regulatory Path 26
Figure 5: Injectable Drug Delivery - Pipeline Products by Estimated Approval Date 27
Figure 6: Injectable Drug Delivery - Ongoing Clinical Trials 28

Companies Profiled

Aciont Inc.
Actavis Inc.
AdrenaCard, Inc.
Allergan, Inc.
Alsensa ApS
AMAG Pharmaceuticals, Inc.
Amgen Inc.
Antares Pharma, Inc.
Anterion Therapeutics, Inc.
Arnali, LLC
Artemes Technologies, Inc.
AstraZeneca Plc
Atanse, Inc.
AzureBio, S.L.
Becton, Dickinson and Company
Bespak Europe Ltd.
Biodel Inc.
BioMarin Pharmaceutical Inc.
BioRestorative Therapies, Inc.
Boston University
BTG Plc
Burke Pharmaceuticals, LLC
Callisyn Biomedical Inc
Cambridge Consultants Limited
Case Western Reserve University
Cincinnati Children's Hospital Medical Center
Clearside BioMedical, Inc.
Consort Medical plc
Credence MedSystems, Inc.
CrossCoat Medical LLC
Cytosial Biomedic, S.a.s.
DALI Medical Devices Ltd.
Delcath Systems, Inc.
DelSite, Inc.
Elcam Medical
EmboMedics
Emergent BioSolutions Inc.
Eveon SAS
Ghent University
Hannover Medical School
Indian Institute of Science
Inovio Pharmaceuticals, Inc.
LyoGo
Medicom Innovation Partner a/s
Meridian Medical Technologies, Inc.
Mertiva AB
Microchips Biotech, Inc.
Midatech Pharma Plc
Milestone Scientific Inc.
North Carolina State University
Ocelus
Oval Medical Technologies Limited
Particle Therapeutics Ltd
Pfizer Inc.
Portal Instruments, Inc.
pSivida Corp.
Ratio, Inc.
Recon Therapeutics, LLC
Replenish Inc
RepliCel Life Sciences, Inc.
RetinaPharma Technologies, Inc.
Rx Safes, Inc.
Scandinavian Health Ltd
Shire Plc
Spine Smith, LP
Sun Pharmaceutical Industries Limited
TCB medical devices
Teva Pharmaceutical Industries Ltd.
Texas Tech University
TheraKine Ltd.
Unilife Corporation
United Therapeutics Corporation
University College London
University of Auckland
University of Calgary
University of California, Irvine
University of California, San Diego
University of California, San Francisco
University of Delaware
University of Dundee
University of Florida
University of Missouri
University of Saskatchewan
University of Texas at Austin
Urodelia SA
Vanderbilt University

Market Reports Center © Copyright 2017 All rights reserved.

wire transfer
ssl